M S Osato

Author PubWeight™ 60.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 1997 2.47
2 Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis 1998 2.38
3 Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect 2000 1.97
4 Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 2001 1.68
5 Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med 2001 1.65
6 Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004 1.57
7 Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis 2004 1.51
8 The effects of freezing and antibiotics on the viability of Acanthamoeba cysts. Arch Ophthalmol 1989 1.42
9 Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother 2000 1.42
10 Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol 2001 1.40
11 Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother 1999 1.38
12 Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 2000 1.19
13 Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 2000 1.18
14 Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol 1986 1.13
15 Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis 2000 1.12
16 DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother 2001 1.11
17 Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther 2000 1.09
18 Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study. Gastrointest Endosc 1999 1.06
19 Bacterial contamination of eyedrop dispensers. Am J Ophthalmol 1984 1.05
20 Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother 2001 1.04
21 Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 2003 1.03
22 Helicobacter pylori in sheep milk. Lancet 1999 1.00
23 Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003 0.96
24 Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates. J Antimicrob Chemother 2000 0.96
25 Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiol Lett 2000 0.94
26 Experimental evaluation of chlorhexidine gluconate for ocular antisepsis. Antimicrob Agents Chemother 1984 0.92
27 Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. Helicobacter 1998 0.92
28 H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori. Am J Gastroenterol 2000 0.92
29 Infectious crystalline keratopathy. The role of bacterial exopolysaccharide. Arch Ophthalmol 1993 0.90
30 Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins. Antimicrob Agents Chemother 1999 0.88
31 In vitro susceptibilities of ocular Bacillus cereus isolates to clindamycin, gentamicin, and vancomycin alone or in combination. Antimicrob Agents Chemother 1991 0.88
32 Characterization of a culture method to recover Helicobacter pylori from the feces of infected patients. Helicobacter 2000 0.86
33 Helicobacter pylori infection in children of Texas. J Pediatr Gastroenterol Nutr 2000 0.86
34 The value of calcofluor white in the diagnosis of mycotic and Acanthamoeba infections of the eye and ocular adnexa. Ophthalmology 1987 0.86
35 The contribution of bacterial surface hydrophobicity to the process of adherence of Pseudomonas aeruginosa to hydrophilic contact lenses. Curr Eye Res 1989 0.86
36 Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther 2000 0.85
37 Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 1999 0.85
38 The autoimmune nature of aqueous tear deficiency. Ophthalmology 1986 0.85
39 Failure to isolate Helicobacter pylori from stray cats indicates that H. pylori in cats may be an anthroponosis--an animal infection with a human pathogen. J Med Microbiol 1997 0.84
40 Comparative bioavailability and efficacy of fortified topical tobramycin. Invest Ophthalmol Vis Sci 1987 0.84
41 Endogenous Candida albicans endophthalmitis in the rabbit. Chemotherapy for systemic effect. Arch Ophthalmol 1981 0.83
42 Direct activity of recombinant human lactoferrin against Helicobacter pylori. J Clin Microbiol 1996 0.83
43 Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying. Aliment Pharmacol Ther 2001 0.83
44 Improved detection of oculomycoses using induced fluorescence with cellufluor. Ophthalmology 1986 0.80
45 Quantitative and bioluminescent assay to measure efficacy of conventional and DNA vaccinations against Helicobacter pylori. Comb Chem High Throughput Screen 2000 0.80
46 Tobramycin in ophthalmology. Surv Ophthalmol 1988 0.80
47 Comparison of acridine orange and Gram stains in bacterial keratitis. Am J Ophthalmol 1988 0.79
48 Quantitative RT-PCR analysis of multiple genes encoding putative metronidazole nitroreductases from Helicobacter pylori. Int J Antimicrob Agents 2000 0.79
49 Capnocytophaga keratitis. Br J Ophthalmol 1985 0.79
50 Folk yoghurt kills Helicobacter pylori. J Appl Microbiol 2002 0.78
51 Neurotoxicity of iohexol: a new nonionic contrast medium. Radiology 1982 0.78
52 Is antrum or corpus the best site for culture of Helicobacter pylori? Helicobacter 1996 0.78
53 Culture of Helicobacter pylori: effect of preimmersion of biopsy forceps in formalin. Helicobacter 1996 0.77
54 Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Aliment Pharmacol Ther 2001 0.77
55 Use of a dry-plasma collection device to overcome problems with storage and transportation of blood samples for epidemiology studies in developing countries. Clin Diagn Lab Immunol 2000 0.75
56 Laundry brighteners and amebic cysts. N Engl J Med 1994 0.75
57 Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis. Aust N Z J Ophthalmol 1993 0.75
58 Disinfection of biopsy forceps and culture of Helicobacter pylori from gastric mucosal biopsies. Am J Gastroenterol 1999 0.75
59 Rapid streptococcal antigen detection in experimental keratitis. Am J Ophthalmol 1989 0.75
60 Photomicrography of Acanthamoeba cysts in human cornea. Am J Ophthalmol 1988 0.75
61 One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. Dig Dis Sci 1998 0.75
62 Combination drug testing of Mycobacterium chelonae. Invest Ophthalmol Vis Sci 1993 0.75
63 Intracanalicular collagen implants enhance topical antibiotic bioavailability. Cornea 1986 0.75
64 The effects of fibronectin on the adherence of bacteria to corneal epithelium. Cornea 1991 0.75
65 The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates--correction. Am J Ophthalmol 1991 0.75
66 The solubility of antibiotic and corticosteroid combinations. Am J Ophthalmol 1992 0.75
67 Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Aliment Pharmacol Ther 1999 0.75